4//SEC Filing
Eizen Joshua M 4
Accession 0000950170-24-121591
CIK 0001880438other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 4:51 PM ET
Size
8.0 KB
Accession
0000950170-24-121591
Insider Transaction Report
Form 4
Eizen Joshua M
See Remarks
Transactions
- Award
Stock Option (right to buy)
2024-11-04+63,000→ 63,000 totalExercise: $1.08Exp: 2034-11-03→ Common Stock (63,000 underlying) - Award
Common Stock
2024-11-04+31,500→ 126,335 total
Footnotes (4)
- [F1]Represents a grant of restricted stock units ("RSUs"). RSUs vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024 until fully vested on November 4, 2028, subject to the Reporting Person's continuous service as of such date.
- [F2]Includes (a) a balance of 30,000 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2024 and (b) a balance of 60,000 RSUs which vest as follows: 1/4th of the RSUs vest on January 1, 2025, 1/2 of the RSUs vest on January 1, 2026 and 1/4th of the RSUs vest on July 1, 2026, subject to the Reporting Person's continuous service as of such date.
- [F3]Reflects the adjusted total which includes the purchase of 2,386 shares under the Issuer's 2022 Employee Stock Purchase Plan on March 31, 2024 and 2 shares under the Issuer's 2022 Employee Stock Purchase Plan on September 30, 2024.
- [F4]The shares subject to the option are exercisable and vest as follows: 1/48th of the shares vest and becomes exercisable monthly over four years from November 4, 2024 until fully vested and exercisable on November 4, 2028, subject to the Reporting Person's continuous service as of such date.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001949621
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 4:51 PM ET
- Size
- 8.0 KB